E. Nadal

831 total citations
18 papers, 587 citations indexed

About

E. Nadal is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, E. Nadal has authored 18 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in E. Nadal's work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). E. Nadal is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). E. Nadal collaborates with scholars based in Spain, United Kingdom and United States. E. Nadal's co-authors include Eduardo Olavarría, E Montserrat, Jane F. Apperley, Francesco Dazzi, John M. Goldman, Jordi Esteve, Laura Rosiñol, Nicole Mahy, Montserrat Vila and Josep Saura and has published in prestigious journals such as Life Sciences, British Journal of Haematology and Leukemia.

In The Last Decade

E. Nadal

18 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Nadal Spain 13 388 207 162 140 113 18 587
Gabriella Benetton Italy 8 205 0.5× 207 1.0× 92 0.6× 88 0.6× 169 1.5× 13 592
Carine Chaleteix France 9 256 0.7× 192 0.9× 329 2.0× 121 0.9× 64 0.6× 22 607
Sandra Tong United States 9 177 0.5× 87 0.4× 74 0.5× 79 0.6× 61 0.5× 18 394
Rana Baraz Australia 10 237 0.6× 227 1.1× 174 1.1× 67 0.5× 185 1.6× 13 559
Miriam Puttini Italy 7 260 0.7× 134 0.6× 87 0.5× 200 1.4× 14 0.1× 8 446
Carl Högberg Sweden 12 184 0.5× 159 0.8× 87 0.5× 43 0.3× 165 1.5× 18 466
Adrian Tempescul France 12 89 0.2× 125 0.6× 110 0.7× 133 0.9× 139 1.2× 46 408
Adriana Puma Italy 12 163 0.4× 141 0.7× 93 0.6× 140 1.0× 22 0.2× 22 452
Christine Flefleh United States 9 139 0.4× 111 0.5× 159 1.0× 104 0.7× 31 0.3× 13 409

Countries citing papers authored by E. Nadal

Since Specialization
Citations

This map shows the geographic impact of E. Nadal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Nadal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Nadal more than expected).

Fields of papers citing papers by E. Nadal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Nadal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Nadal. The network helps show where E. Nadal may publish in the future.

Co-authorship network of co-authors of E. Nadal

This figure shows the co-authorship network connecting the top 25 collaborators of E. Nadal. A scholar is included among the top collaborators of E. Nadal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Nadal. E. Nadal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fozza, Claudio, Richard Szydlo, E. Nadal, et al.. (2007). Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose. British Journal of Haematology. 136(6). 833–836. 20 indexed citations
2.
Nadal, E., Marina Garín, Jaspal Kaeda, et al.. (2007). Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia. 21(3). 472–479. 45 indexed citations
3.
Fozza, Claudio, E. Nadal, Maurizio Longinotti, & Francesco Dazzi. (2007). T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25 counterpart. Haematologica. 92(2). 206–214. 14 indexed citations
4.
Simula, Maria Paola, Sarah Marktel, Claudio Fozza, et al.. (2007). Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia. 21(5). 943–948. 34 indexed citations
5.
Nadal, E., Jaspal Kaeda, Jane F. Apperley, Robert I. Lechler, & Francesco Dazzi. (2007). 33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML). Biology of Blood and Marrow Transplantation. 13(2). 15–15. 1 indexed citations
6.
Terpos, Evangelos, Marianna Politou, Richard Szydlo, et al.. (2004). Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma. Leukemia. 18(8). 1420–1426. 51 indexed citations
7.
Nadal, E. & Eduardo Olavarría. (2004). Imatinib mesylate (Gleevec/Glivec) a molecular-targeted therapy for chronic myeloid leukaemia and other malignancies. International Journal of Clinical Practice. 58(5). 511–516. 43 indexed citations
8.
Nadal, E., Eva Giné, Joan Bladé, et al.. (2004). High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplantation. 33(1). 61–64. 41 indexed citations
9.
Avery, S, E. Nadal, David Marín, et al.. (2004). Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib. Leukemia Research. 28. 75–77. 9 indexed citations
10.
Nadal, E., et al.. (2004). Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions. Experimental Hematology. 32(2). 218–223. 29 indexed citations
11.
12.
Rosiñol, Laura, Joan Bladé, Jordi Esteve, et al.. (2003). Smoldering multiple myeloma: natural history and recognition of an evolving type. British Journal of Haematology. 123(4). 631–636. 95 indexed citations
13.
Montoto, Silvia, Marı́a Rozman, Laura Rosiñol, et al.. (2003). Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Seminars in Oncology. 30(2). 178–181. 10 indexed citations
14.
Nadal, E., Antonio Martı́nez, Àngels Ginès, et al.. (2002). Primary follicular lymphoma arising in the ampulla of Vater. Annals of Hematology. 81(4). 228–231. 19 indexed citations
15.
Cobo, Francesc, Laura Rosiñol, Antonio Martı́nez, et al.. (2002). Limitations of Gallium‐67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome. British Journal of Haematology. 119(2). 484–487. 10 indexed citations
16.
Nadal, E., et al.. (2001). Hypercalcemia as the Presenting Feature of T-Cell Lymphoid Blast Crisis of Ph-Positive Chronic Myeloid Leukemia. Leukemia & lymphoma. 41(1-2). 203–206. 9 indexed citations
17.
Cervantes, Francisco, et al.. (2000). Danazol treatment of idiopathic myelofibrosis with severe anemia.. PubMed. 85(6). 595–9. 48 indexed citations
18.
Saura, Josep, E. Nadal, B. van den Berg, et al.. (1996). Localization of monoamine oxidases in human peripheral tissues. Life Sciences. 59(16). 1341–1349. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriella Benetton Breakdown of academic impact, for papers by Carine Chaleteix Breakdown of academic impact, for papers by Sandra Tong Breakdown of academic impact, for papers by Rana Baraz Breakdown of academic impact, for papers by Miriam Puttini Breakdown of academic impact, for papers by Carl Högberg Breakdown of academic impact, for papers by Adrian Tempescul Breakdown of academic impact, for papers by Adriana Puma Breakdown of academic impact, for papers by Christine Flefleh
Rankless by CCL
2026